PlainIndex

ETF comparison

ASHR vs FNDE

Both International Emerging.

Xtrackers Harvest CSI 300 China A-Shares ETF · Schwab Fundamental Emerging Markets Equity ETF

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of ASHR and FNDE would leave roughly 0.0% of each dollar exposed to the same underlying securities.

ASHR only 0.0% Shared 0.0% FNDE only 0.0%
In ASHR only
0 positions
Shared
0 positions
In FNDE only
0 positions

Holdings data for ASHR covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for FNDE covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

ASHR

Xtrackers Harvest CSI 300 China A-Shares ETF

DWS · International Emerging

53 composite / 100
Expense ratio
0.65%
Net assets
$1.83B
TTM yield
2.17%
Top-10 conc.
—
FNDE

Schwab Fundamental Emerging Markets Equity ETF

Schwab · International Emerging

73 composite / 100
Expense ratio
0.39%
Net assets
$9.36B
TTM yield
3.76%
Top-10 conc.
—

Sub-score comparison

35
Cost
61
72
Tax efficiency
66
68
Liquidity
99
N/A
Concentration
N/A
—
Tracking quality
—
ASHR sub-score FNDE

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

FNDE is 26 bps cheaper than ASHR. On a $100,000 position that's about $260/yr more in fees for ASHR.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in ASHR

0 total

Every ASHR position is also held by FNDE.

Only in FNDE

0 total

Every FNDE position is also held by ASHR.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.